Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
348.2 USD | -0.33% |
|
+2.59% | +16.27% |
Jun. 04 | Stryker Releases Lifepak 35 Monitor/Defibrillator | CI |
Jun. 03 | Stryker to Acquire Artelon | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.01 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.27% | 133B | A- | ||
-4.36% | 11.4B | A- | ||
-4.86% | 8.3B | C | ||
+42.16% | 5.69B | B+ | ||
-20.87% | 4.78B | C | ||
+7.73% | 3.42B | C- | ||
-19.39% | 2.48B | B- | ||
-13.36% | 2.03B | - | - | |
-16.39% | 1.86B | - | ||
-31.24% | 1.59B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SYK Stock
- Ratings Stryker Corporation